ZVSA (ZyVersa Therapeutics) Insider Ownership: 6.64 % (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ZyVersa Therapeutics Insider Ownership?

ZyVersa Therapeutics ZVSA -0.20% Insider Ownership is 6.64 % as of Sep. 10, 2026. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ZyVersa Therapeutics's insider ownership is 6.64%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ZyVersa Therapeutics's Institutional Ownership is 0.82%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ZyVersa Therapeutics's Float Percentage Of Total Shares Outstanding is 99.85%.

ZyVersa Therapeutics Insider Ownership Historical Data

* Premium members only.

The historical data trend for ZyVersa Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZyVersa Therapeutics Insider Ownership Chart

ZyVersa Therapeutics Historical Data

The historical data trend for ZyVersa Therapeutics can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 6.64 6.64 6.64 6.64 6.64 6.64 6.64 6.64 6.64 6.64

ZyVersa Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 6.64 % mean?
ZyVersa Therapeutics (ZVSA) has a Insider Ownership of 6.64 % as of Sep. 10, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ZyVersa Therapeutics and its competitors.
Is ZyVersa Therapeutics' Insider Ownership too high?
ZyVersa Therapeutics' current Insider Ownership is 6.64 %.
How does ZyVersa Therapeutics' Insider Ownership compare to AGTX and CERO?
ZyVersa Therapeutics' Insider Ownership of 6.64 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ZyVersa Therapeutics and its competitors. ZyVersa Therapeutics's current Insider Ownership is 6.64 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZyVersa Therapeutics stock overvalued right now?
ZyVersa Therapeutics (ZVSA) has a current Insider Ownership of 6.64 %. The current Insider Ownership is 6.64 %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For ZyVersa Therapeutics (ZVSA), the current Insider Ownership is 6.64 % as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ZyVersa Therapeutics Business Description

Address 2200 North Commerce Parkway, Suite 208, Weston, FL, USA, 33326
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.